Can-Fite BioPharma (CANF) Short Interest Ratio & Short Volume

Short interest is the volume of Can-Fite BioPharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 146,700 shares of CANF short. Learn More on Can-Fite BioPharma's current short interest.

Can-Fite BioPharma saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 146,700 shares, a decline of 52.4% from the previous total of 308,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Can-Fite BioPharma: Equillium, Inc. (0.66%), MEI Pharma, Inc. (0.03%), NextCure, Inc. (1.48%), Eterna Therapeutics Inc. (0.52%), AlloVir, Inc. (2.56%), Edesa Biotech, Inc. (0.37%), Rallybio Co. (1.80%), Moleculin Biotech, Inc. (7.01%), Unity Biotechnology, Inc. (4.82%), 23andMe Holding Co. (11.90%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling CANF is an investing strategy that aims to generate trading profit from Can-Fite BioPharma as its price is falling. CANF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Can-Fite BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CANF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CANF, twice per month. The most recent reporting period available is May, 15 2025.